Home
       
STOCK MARKETS


Back

10 Last viewed shares   
 
President’s Message
  President’s Message
  Mind-Controlled Innovation As a global leader in prosthetics and bracing and supports, we at Össur never stop innovating. We are resolute in our commitment to ...
  Read more... 
Strategy & Goals
  Strategy & Goals
  DEVELOPMENT CONCEPTS AND OBJECTIVE With the ultimate goal to stay as an innovator and a leader in the bio-pharmaceutical industry, the Group has committed to ...
  Read more... 
Year in Brief
  Year in Brief
  2014 Main Highlights January Launched renal anemia treatment NESP ® Injection 5μg Plastic Syringe in Japan February Added new information covering pollinosis ...
  Read more... 
   

Epigenomics AG

    Print this page Print this page    Send to a Friend E-mail this page to your friend    Disclaimer

SHARE DATA GRAPH TECHNICAL ANALYSIS
Select class of Share
Epigenomics (XETRA)‎  
Last 0,70      Change % 0,00 
Add to Portfolio
Add to Watchlist
Add to Alerts

10 LAST TRADES EUR
Time Last Volume
Displayed time is based on the time zone of your choice on Euroland.com
Refresh
ChartImage
 
QUOTES EUR
Time 2024-06-27
Last 0,70
Change % 0,00 
Change 0,00 
Bid/Ask 1,86 / 1,86
Open 0,52
High/Low 0,70 / 0,52
Volume 0
Previous Close 0,70
52 Weeks High 2,55
52 Weeks Low 0,44
52 Weeks %   -6,67 
YTD %   -62,97 
Volatility N/A
Beta N/A
Correlation N/A
MARKET DATA
Symbol ECX
Market  XETRA
List  Open Market
Domestic Industry  Pharmaceutical & Healthcare
Euroland-Industry  Biotechnology
Shares (mil)1 4,27
Market Cap (mil) 2,99
1 - Number of shares in specific class of share. Otherwise it is total number of shares issued.

INDICES
 Technology All Share
 Prime All Share

Data delayed at least 15 minutes. From Hanoi & HoChiMinh data is real time. From Milan, Dublin & Tokyo data is as end of day.
Data provided by vwd group Switzerland AG & MOEX.

 
 
   Privacy Policy | Disclaimer | Set this page as your homepage| © Euroland.com 2000-2024